Newest Techniques for Opening Arterial Blockages to Be Highlighted at Annual Coronary and Vascular Symposium
Mount Sinai Heart is hosting the13th Annual Live Symposium of Complex Coronary and Cardiovascular Cases.
The most advanced equipment and procedures for opening occluded arteries will be explored in-depth from Wednesday, June 16, to Saturday, June 19, at the 13th Annual Live Symposium of Complex Coronary and Cardiovascular Cases at The Mount Sinai Medical Center in New York City. Detailed information is on the Web at www.cccsymposium.org.
Hosted by Mount Sinai Heart, the focus of the symposium will be to present a multi-device approach to revascularization of patients with complex coronary and cardiovascular disease. Due to growing demand, special attention will be paid to the field of endovascular specialty with a simultaneous dedicated one-day program, including live cases and didactic discussion, on Friday, June 18.
In the symposium numerous new devices and techniques for coronary intervention will be introduced. This year’s symposium will be the first in New York to feature the clinical use of a recently approved, novel imaging modality called OCT (Optical Coherence Tomography). OCT technology allows visualizing, in real time, the condition of artery and stents in microscopic details. These will enable interventionalists to assess the coronary plaque’s detail (fat content, clot or scar tissue) and optimal stent deployment, and its healing process (endothelization). Infrared spectroscopy identifying lipid contents (yellow fat) of the plaque (Lipiscan) will be another imaging modality showcased.
The symposium will begin Wednesday, June 16 at 8 am with an all-day program for cardiac nurses and technicians. The general session will take place Thursday and Friday, June 17 and 18, and begin with “Top Ten Advances of Interventional Cardiology 2009” presented by Samin Sharma, MD, Director of Cardiac Catheterization Labs at Mount Sinai Heart.
To provide the glimpses of future innovations, a live transmission relay of percutaneous aortic valve implantation (TAVI) from Germany has been planned for Thursday, June 17, from 1:30 – 2:30 pm. Other highlights include: presentations on novel interventional devices and techniques such as distal protection device, septal ablation, retrograde recanalization of totally occluded arteries; discussions on technical issues regarding treatment of emerging problems including unprotected left main disease and DES restenosis; and live case presentations and interventional debates.
The 13th Annual Live Symposium of Complex Coronary and Cardiovascular Cases is presented by The Zena and Michael A. Weiner Cardiovascular Institute and the Marie-Josee and Henry R. Kravis Center for Cardiovascular Health of Mount Sinai. The event is sponsored by The Page and William Black Post-Graduate School of Mount Sinai School of Medicine.
MEDIA ARE INVITED TO ATTEND WHOLE OR PARTIAL SESSIONS.
PLEASE CONTACT THE MOUNT SINAI PRESS OFFICE AT (212) 241-9200.
About Mount Sinai Heart
Mount Sinai Heart is a national leader in cardiac care and vascular surgery, offering expertise in the areas of cardiology, cardiovascular surgery, medical education, research, and community service, with state-of-the-art imaging and patient care facilities, advanced laboratories for scientific research, and leading programs for postgraduate education of clinician-scientists. The Cardiac Catheterization Laboratory is both the busiest in New York State—and the safest, with the lowest 30-day risk-adjusted mortality rate, according to an April 2010 study conducted by the New York State Department of Health.
Mount Sinai physicians were the first in the country to perform a non-surgical procedure to tie off a left atrial appendage as well as the first to ablate atrial fibrillation using a visually-guided laser balloon catheter. The procedures were performed in August and September 2009, respectively. Within the 20,000-square-foot Mount Sinai Imaging Science Laboratories, the faculty creates, develops and applies innovative and advanced-imaging technologies toward building a more comprehensive understanding and treatment of the human body.
About The Mount Sinai Medical Center
The Mount Sinai Medical Center encompasses both The Mount Sinai Hospital and Mount Sinai School of Medicine. Established in 1968, Mount Sinai School of Medicine is one of few medical schools embedded in a hospital in the United States. It has more than 3,400 faculty in 32 departments and 15 institutes, and ranks among the top 20 medical schools both in National Institute of Health funding and by U.S. News & World Report. The school received the 2009 Spencer Foreman Award for Outstanding Community Service from the Association of American Medical Colleges.
The Mount Sinai Hospital, founded in 1852, is a 1,171-bed tertiary- and quaternary-care teaching facility and one of the nation’s oldest, largest and most-respected voluntary hospitals. In 2009, U.S. News & World Report ranked The Mount Sinai Hospital among the nation’s top 20 hospitals based on reputation, patient safety, and other patient-care factors. Nearly 60,000 people were treated at Mount Sinai as inpatients last year, and approximately 530,000 outpatient visits took place.
For more information, visit www.mountsinai.org.